Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  5, 503 - 507 (2004)
Published online: 4 April 2004; | doi:10.1038/ni1061

RIP1 is an essential mediator of Toll-like receptor 3−induced NF-kappaB activation

Etienne Meylan1, Kim Burns1, Kay Hofmann2, Vincent Blancheteau1, Fabio Martinon1, Michelle Kelliher3 & Jürg Tschopp1

1  Department of Biochemistry, University of Lausanne, BIL Biomedical Research Center, Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.

2  MEMOREC Stoffel GmbH, Stoeckheimer Weg 1, D-50829 Koeln, Germany.

3  University of Massachusetts Medical School, Department of Cancer Biology, Worcester, Massachusetts 01605, USA.

Correspondence should be addressed to Jürg Tschopp jurg.tschopp@ib.unil.ch
Stimulation of Toll-like receptors (TLRs) initiates potent innate immune responses through Toll−interleukin 1 receptor (TIR) domain−containing adaptors such as MyD88 and Trif. Analysis of Trif-deficient mice has shown that TLR3-dependent activation of the transcription factor NF-kappaB by the TLR3 ligand double-stranded RNA is Trif dependent. Here we investigated the 'downstream' signaling events that regulate TLR3-dependent Trif-induced NF-kappaB activation. Trif recruited the kinases receptor interacting protein (RIP)-1 and RIP3 through its RIP homotypic interaction motif. In the absence of RIP1, TLR3-mediated signals activating NF-kappaB, but not the kinase JNK or interferon-beta, were abolished, suggesting that RIP1 mediates Trif-induced NF-kappaB activation. In contrast, the presence of RIP3 negatively regulated the Trif-RIP1−induced NF-kappaB pathway. Therefore, in contrast to other TLRs, which use interleukin 1 receptor-associated kinase (IRAK) proteins to activate NF-kappaB, TLR 3-induced NF-kappaB activation is dependent on RIP kinases.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Toll signaling: RIPping off the TNF pathway

Nature Immunology News and Views (01 May 2004)

IRAK2 takes its place in TLR signaling

Nature Immunology News and Views (01 Jun 2008)

See all 8 matches for News And Views
 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Nov 29 2009
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

Figures & Tables
See also: News and Views by Barton & Medzhitov
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy